Clinical and pathological disappearance of peritoneal dissemination in a patient with advanced gastric cancer receiving chemotherapy with S-1 and low-dose cisplatin

被引:4
|
作者
Akatsu Y. [1 ]
Saikawa Y. [1 ]
Kubota T. [1 ]
Yoshida M. [1 ]
Furukawa T. [1 ]
Otani Y. [1 ]
Kumai K. [2 ]
Kitajima M. [1 ]
机构
[1] Department of Surgery, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582
[2] Ctr. for Diagn./Therapeut. Endoscopy, Keio University School of Medicine, Tokyo
关键词
Cisplatin; Gastric cancer; Peritoneal dissemination; S-1;
D O I
10.1007/s10120-004-0281-8
中图分类号
学科分类号
摘要
A 54-year-old woman with severe abdominal distention suffered from massive ascites. Cytological examination revealed adenocareinoma cells, leading to a diagnosis of peritonitis carcinomatosa. Gastrointestinal fiberseopy (GIF) resulted in a histological diagnosis of type 4 advanced gastric cancer with signet-ring cell carcinoma. The clinical diagnosis was confirmed to be cT3(SE)cN1cM0cH0cP1, cStage IV gastric cancer, type 4, according to the Japanese classification of gastric carcinoma. The patient was treated with S-1 and low-dose cisplatin (CDDP) in order to alleviate the critical state of the disease. After the third cycle of the regimen, the clinical response of P1 was classified as a partial response (PR) according to the World Health Organization (WHO) criteria. The patient's appetite loss and abdominal discomfort were markedly alleviated. The patient experienced grade 2 leukocytopenia throughout the regimen. Surgery was performed. Ascites and peritoneal disseminated lesions were not observed, and cytological examination of the peritoneal washes was negative. Total gastrectomy with D1 lymph node dissection was performed, and the surgical diagnosis was sT3(SE)sN0sM0sH0sP0; sStage II Microscopically, viable cancer cells were found to be scattered throughout the subserosal-serosal layers in the resected stomach. All of the samples from lesions that were potentially cancers involving peritoneal dissemination were diagnosed as fibrous scar tissues without any viable cancer cells. The patient is alive without recurrence at 10 months after surgery and 14 months after the initial chemotherapy. Thus, systemic chemotherapy with S-1/low-dose CDDP achieved desirable control of peritoneal disseminated cells, as assessed microscopically, suggesting that the regimen may be an effective strategy for the treatment of advanced gastric cancer with peritonitis carcinomatosa.
引用
收藏
页码:128 / 133
页数:5
相关论文
共 50 条
  • [31] Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer
    Kinro Sasaki
    Shinichi Onodera
    Kichiro Otsuka
    Hitoshi Satomura
    Eigo Kurayama
    Tsukasa Kubo
    Masakazu Takahashi
    Jun Ito
    Masanobu Nakajima
    Satoru Yamaguchi
    Kazuhito Miyachi
    Hiroyuki Kato
    Medical Oncology, 2017, 34
  • [32] Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis
    Giorgi Nadiradze
    Urs Giger-Pabst
    Juergen Zieren
    Dirk Strumberg
    Wiebke Solass
    Marc-André Reymond
    Journal of Gastrointestinal Surgery, 2016, 20 : 367 - 373
  • [33] Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis
    Nadiradze, Giorgi
    Giger-Pabst, Urs
    Zieren, Juergen
    Strumberg, Dirk
    Solass, Wiebke
    Reymond, Marc-Andre
    JOURNAL OF GASTROINTESTINAL SURGERY, 2016, 20 (02) : 367 - 373
  • [34] Efficacy and Feasibility of Combination Chemotherapy with S-1 and Cisplatin (2 Weeks Regimen) for Advanced Gastric Cancer
    Abe, Seiichiro
    Tsuji, Yasushi
    Tsushima, Takahiro
    Kogawa, Takahiro
    Abe, Masakazu
    Onodera, Yoshimitsu
    Mizushima, Takeshi
    Kukitsu, Takehiro
    Sumiyoshi, Tetsuya
    Yoshizaki, Naohito
    Ishii, Toru
    Kondo, Hitoshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (04) : 302 - 306
  • [35] Two cases of gastric cancer with peritoneal carcinomatosis successfully responding to combination chemotherapy of S-1 and cisplatin, leading to clinical complete response
    Suzuki, Shuhei
    Ito, Yuriko
    Fukui, Tadahisa
    Orihara, Mika
    Nakamura, Sho
    Takahashi, Masahiro
    Fujimoto, Hiroto
    Kimura, Wataru
    Yoshioka, Takashi
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2013, 2 (04): : 201 - 205
  • [36] A randomized phase II study comparing S-1 plus weekly split-dose cisplatin with S-1 plus standard-dose cisplatin as first-line chemotherapy for advanced gastric cancer
    Toshikazu Moriwaki
    Shinji Hirai
    Shuichi Hironaka
    Kenji Amagai
    Atsuko Soeda
    Mikio Sato
    Takeshi Nihei
    Mitsuaki Hirose
    Kenji Matsuda
    Atsushi Ohkawara
    Taketo Yamaguchi
    Mitsuharu Ozeki
    Takashi Mamiya
    Tetsuya Murashita
    Ichinosuke Hyodo
    Gastric Cancer, 2014, 17 : 354 - 361
  • [37] Two cases of gastric cancer with peritoneal carcinomatosis successfully responding to combination chemotherapy of S-1 and cisplatin, leading to clinical complete response
    Shuhei Suzuki
    Yuriko Ito
    Tadahisa Fukui
    Mika Orihara
    Sho Nakamura
    Masahiro Takahashi
    Hiroto Fujimoto
    Wataru Kimura
    Takashi Yoshioka
    International Cancer Conference Journal, 2013, 2 (4) : 201 - 205
  • [38] Phase 2 trial of oral S-1 combined with low-dose cisplatin for unresectable advanced pancreatic cancer
    Ina, Shinomi
    Tani, Masaji
    Kawai, Manabu
    Hirono, Seiko
    Miyazawa, Motoki
    Nishioka, Ryohei
    Fujita, Yoichi
    Yamaue, Hiroki
    ANTICANCER RESEARCH, 2008, 28 (4C) : 2373 - 2377
  • [39] A randomized phase II study comparing S-1 plus weekly split-dose cisplatin with S-1 plus standard-dose cisplatin as first-line chemotherapy for advanced gastric cancer
    Moriwaki, Toshikazu
    Hirai, Shinji
    Hironaka, Shuichi
    Amagai, Kenji
    Soeda, Atsuko
    Sato, Mikio
    Nihei, Takeshi
    Hirose, Mitsuaki
    Matsuda, Kenji
    Ohkawara, Atsushi
    Yamaguchi, Taketo
    Ozeki, Mitsuharu
    Mamiya, Takashi
    Murashita, Tetsuya
    Hyodo, Ichinosuke
    GASTRIC CANCER, 2014, 17 (02) : 354 - 361
  • [40] Adjuvant S-1 Chemotherapy for Gastric Cancer and Peritoneal Wash
    Seiji Ito
    World Journal of Surgery, 2011, 35 : 470 - 471